Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Mayer

Showing results (721-730 of 1,107) with videos related to

Pageof 111
Sort By:
Translational Behavioral Medicine|August 28, 2021
Development of a digital pill and respondent behavioral intervention (PrEPSteps) for HIV pre-exposure prophylaxis adherence among stimulant using men who have sex with menPeter R Chai, Yassir Mohamed, Georgia Goodman, et al.
AIDS Patient Care and Stds|November 11, 2022
Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis StudyPablo K Valente, José A Bauermeister, Willey Y Lin, et al.
AIDS Patient Care and Stds|February 10, 2025
Telehealth Interventions to Improve HIV Care Continuum Outcomes: A Narrative ReviewDamian Krebs, Hilary Goldhammer, Milo Dorfman, et al.
AIDS and Behavior|February 20, 2016
Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public SupportSarah K Calabrese, Kristen Underhill, Valerie A Earnshaw, et al.
Journal of Women'S Health (2002)|October 30, 2003
The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trialKathleen Morrow, Rochelle Rosen, Linda Richter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African womenRochelle P Walensky, Ji-Eun Park, Robin Wood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2009
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settingsN Kumarasamy, Vidya Madhavan, Kartik K Venkatesh, et al.
Journal of the International Association of Providers of AIDS Care|October 7, 2016
Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and PreventionKate Buchacz, Jennifer Farrior, Geetha Beauchamp, et al.
AIDS and Behavior|November 17, 2016
Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP"Kenneth H Mayer, Steven A Safren, Steven A Elsesser, et al.
Archives of Sexual Behavior|February 23, 2017
Sexual Stereotypes Ascribed to Black Men Who Have Sex with Men: An Intersectional AnalysisSarah K Calabrese, Valerie A Earnshaw, Manya Magnus, et al.
Pageof 111

Showing results (721-730 of 1,107) with videos related to

Sort By:
Pageof 111
Translational Behavioral Medicine|August 28, 2021
Development of a digital pill and respondent behavioral intervention (PrEPSteps) for HIV pre-exposure prophylaxis adherence among stimulant using men who have sex with menPeter R Chai, Yassir Mohamed, Georgia Goodman, et al.
AIDS Patient Care and Stds|November 11, 2022
Preferences Across Pre-Exposure Prophylaxis Modalities Among Young Men Who Have Sex with Men in the United States: A Latent Class Analysis StudyPablo K Valente, José A Bauermeister, Willey Y Lin, et al.
AIDS Patient Care and Stds|February 10, 2025
Telehealth Interventions to Improve HIV Care Continuum Outcomes: A Narrative ReviewDamian Krebs, Hilary Goldhammer, Milo Dorfman, et al.
AIDS and Behavior|February 20, 2016
Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public SupportSarah K Calabrese, Kristen Underhill, Valerie A Earnshaw, et al.
Journal of Women'S Health (2002)|October 30, 2003
The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trialKathleen Morrow, Rochelle Rosen, Linda Richter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African womenRochelle P Walensky, Ji-Eun Park, Robin Wood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2009
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settingsN Kumarasamy, Vidya Madhavan, Kartik K Venkatesh, et al.
Journal of the International Association of Providers of AIDS Care|October 7, 2016
Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and PreventionKate Buchacz, Jennifer Farrior, Geetha Beauchamp, et al.
AIDS and Behavior|November 17, 2016
Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP"Kenneth H Mayer, Steven A Safren, Steven A Elsesser, et al.
Archives of Sexual Behavior|February 23, 2017
Sexual Stereotypes Ascribed to Black Men Who Have Sex with Men: An Intersectional AnalysisSarah K Calabrese, Valerie A Earnshaw, Manya Magnus, et al.
Pageof 111